<html><body><pre>[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6033 Introduced in House (IH)]

&lt;DOC&gt;






114th CONGRESS
  2d Session
                                H. R. 6033

To expand the tropical disease product priority review voucher program 
   to encourage treatments for the Middle East respiratory syndrome.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 14, 2016

   Mr. Peters (for himself, Mr. Rothfus, and Mr. Brendan F. Boyle of 
Pennsylvania) introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To expand the tropical disease product priority review voucher program 
   to encourage treatments for the Middle East respiratory syndrome.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Adding Middle East Respiratory 
Syndrome to the FDA Priority Review Voucher Program Act''.

SEC. 2. EXPANDING TROPICAL DISEASE PRODUCT PRIORITY REVIEW VOUCHER 
              PROGRAM TO ENCOURAGE TREATMENTS FOR MIDDLE EAST 
              RESPIRATORY SYNDROME.

    Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 360n(a)(3)) is amended--
            (1) by redesignating subparagraph (S) as subparagraph (T); 
        and
            (2) by inserting after subparagraph (R) the following:
                    ``(S) Middle East respiratory syndrome.''.
                                 &lt;all&gt;
</pre></body></html>
